LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 39.41 | 27.76 | 1631 | 3105 | 0.5252 | 0.8194 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 39.41 | 27.76 | 44 | 3105 | 0.0142 | 0.0700 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 39.41 | 27.76 | 1721 | 3105 | 0.5542 | 0.8338 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.11 | 27.76 | 49 | 3331 | 0.0147 | 0.0858 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.11 | 27.76 | 1688 | 3331 | 0.5067 | 0.8125 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.11 | 27.76 | 54 | 3331 | 0.0162 | 0.1011 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 41.11 | 27.76 | 1852 | 3331 | 0.5559 | 0.8370 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.81 | 27.76 | 40 | 3596 | 0.0111 | 0.0534 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.81 | 27.76 | 1764 | 3596 | 0.4905 | 0.8070 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.81 | 27.76 | 72 | 3596 | 0.0200 | 0.1455 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.81 | 27.76 | 1945 | 3596 | 0.5408 | 0.8323 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.52 | 27.76 | 48 | 3884 | 0.0124 | 0.0799 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.52 | 27.76 | 1851 | 3884 | 0.4765 | 0.8025 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.52 | 27.76 | 76 | 3884 | 0.0196 | 0.1518 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.52 | 27.76 | 2068 | 3884 | 0.5324 | 0.8307 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.22 | 27.76 | 68 | 4125 | 0.0165 | 0.1322 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.22 | 27.76 | 1935 | 4125 | 0.4691 | 0.8008 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.22 | 27.76 | 65 | 4125 | 0.0158 | 0.1252 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 46.22 | 27.76 | 2180 | 4125 | 0.5285 | 0.8308 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.93 | 27.76 | 58 | 4421 | 0.0131 | 0.1060 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.93 | 27.76 | 2052 | 4421 | 0.4641 | 0.8008 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.93 | 27.76 | 67 | 4421 | 0.0152 | 0.1280 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.93 | 27.76 | 2246 | 4421 | 0.5080 | 0.8231 | MN20160318_Q01 | G15 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 49.63 | 27.76 | 54 | 4818 | 0.0112 | 0.0936 | MN20160318_Q01 | E22 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 49.63 | 27.76 | 2066 | 4818 | 0.4288 | 0.7848 | MN20160318_Q01 | E22 |